OPATUS CPTa: New ways in precise diagnostics and therapy support for optimized treatment results in ADHD and other neuropsychiatric disorders

Description

The OPATUS CPTa objectively measures impulsivity, activity and inattention (which happen to be the core symptoms of ADHD). It is then up to the clinician to decide why/how these entities/parameters can help him/her to best serve the patient in terms of diagnosis or to guide treatments. This also opens up areas of application for other indications such as mental fatigue, Parkinson's disease, schizophrenia or assessments of attention, for example after concussions or other organic brain disorders. For mobile examinations, the CPTa can also be used at work, at school or by the patient at home under clinical guidance. This means that the examination is carried out in a realistic environment and false positive or negative results can be reduced. The test has CE certification in the EU since 2018. In my book "ADHD is curable" I have already pointed out the special advantages of this test and I hope that in the future it will become the general diagnostic standard for ADHD and other neuropsychiatric disorders and thus help to optimize diagnostics and therapy and promote individualized medicine.